Schedule 13G ownership disclosure

CIDARA THERAPEUTICS INC

Common Stock, $0.0001 par value per share · CUSIP: 171757206

Event date: 2025-06-30

Filing-level shares
2,500,680
Percent of class
9.99%
  • BCLS Fund III Investments, LP

    Shares: 2,500,680 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-108820
Form type
SCHEDULE 13G/A
Filer
BCLS Fund III Investments, LP
CIK
CIK 1952107
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub